Journal of the National Cancer Institute Advance Access published online on June 24, 2008
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djn190
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert
Affiliations of authors: Cancer Research UK Department of Oncology (MG, HS, TK, KED, KAP, PDPP, BAJP, AMD), Cancer Research UK Genetic Epidemiology Unit, Department of Public Health and Primary Care (AAAO, JM, DFE), University of Cambridge, Strangeways Research Laboratory, Cambridge, UK; The Institute of Cancer Research, Sutton, Surrey, UK (ZKJ, MG, SME, DPD, ALH, LTO, BNGS, RAW, RAE); Translational Research Laboratories, Institute for Womens Health, University College London, London, UK (SJR, SAG); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (SKK, EH); Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY (RAD); Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (ASW); Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria, Australia (GGG); Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Carlton, Victoria, Australia (GGG, JLH); Department of Social Medicine, University of Bristol, Bristol, UK (JLD); Academic Urology Unit, University of Sheffield, Sheffield, UK (FCH); The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK (DPD, ATAJ, ALH, BNGS, RAE); The Royal Marsden NHS Foundation Trust, London, UK (DPD, ATAJ, ALH, BNGS, RAE); Surgical Oncology (Uro-Oncology: S4), University of Cambridge, Addenbrookes Hospital, UK (DEN); Cancer Research UK Cambridge Cancer Research Institute, Cambridge, UK (BAJP)
Correspondence to: Maya Ghoussaini, PhD, CR-UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, CB1 8RN, Cambridge, UK (e-mail: maya{at}srl.cam.ac.uk).
Recent studies based on genome-wide association, linkage, and admixture scan analysis have reported associations of various genetic variants in 8q24 with susceptibility to breast, prostate, and colorectal cancer. This locus lies within a 1.18-Mb region that contains no known genes but is bounded at its centromeric end by FAM84B and at its telomeric end by c-MYC, two candidate cancer susceptibility genes. To investigate the associations of specific loci within 8q24 with specific cancers, we genotyped the nine previously reported cancer-associated single-nucleotide polymorphisms across the region in four case–control sets of prostate (1854 case subjects and 1894 control subjects), breast (2270 case subjects and 2280 control subjects), colorectal (2299 case subjects and 2284 control subjects), and ovarian (1975 case subjects and 3411 control subjects) cancer. Five different haplotype blocks within this gene desert were specifically associated with risks of different cancers. One block was solely associated with risk of breast cancer, three others were associated solely with the risk of prostate cancer, and a fifth was associated with the risk of prostate, colorectal, and ovarian cancer, but not breast cancer. We conclude that there are at least five separate functional variants in this region.
| Context and Caveats Prior knowledge Genetic variants in a region of chromosome 8 had been associated with the risk of breast, colorectal, and prostate cancer. Study design Case subjects with each of four cancers (breast, colorectal, prostate, and ovarian) and control subjects were examined for the presence of previously identified risk variants that span the chromosomal region previously associated with cancer risk. Genotype frequencies were compared using unconditional logistic regression. Contribution At least five distinct cancer susceptibility loci were found within the chromosomal region, each separated by recombination hot spots and specific for one or more of the four cancers. Implications Fine mapping of the identified loci may help elucidate molecular mechanisms that contribute to carcinogenesis. Limitations It is unknown whether any of the cancer-associated polymorphisms examined are causal variants or simply markers of unknown causal variants.
|
Manuscript received November 27, 2007; revised April 20, 2008; accepted May 14, 2008.
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 907.
This article has been cited by other articles:
![]() |
S.-P. Huang, L.-C. Huang, W.-C. Ting, L.-M. Chen, T.-Y. Chang, T.-L. Lu, Y.-H. Lan, C.-C. Liu, W.-H. Yang, H.-Z. Lee, et al. Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3068 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gu, M. Wang, M. Wang, Z. Zhang, and J. Chen The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies Mutagenesis, November 1, 2009; 24(6): 507 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Middeldorp, S. Jagmohan-Changur, R. van Eijk, C. Tops, P. Devilee, H. F. A. Vasen, F. J. Hes, R. Houlston, I. Tomlinson, J. J. Houwing-Duistermaat, et al. Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3062 - 3067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Stern, D. Van Den Berg, J.-M. Yuan, D. V. Conti, M. Gago-Dominguez, M. C. Pike, Y.-B. Xiang, Y.-T. Gao, and V. K. Cortessis Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3057 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Couch, X. Wang, R. R. McWilliams, W. R. Bamlet, M. de Andrade, and G. M. Petersen Association of Breast Cancer Susceptibility Variants with Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3044 - 3048. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fejerman, C. A. Haiman, D. Reich, A. Tandon, R. C. Deo, E. M. John, S. A. Ingles, C. B. Ambrosone, D. H. Bovbjerg, L. H. Jandorf, et al. An Admixture Scan in 1,484 African American Women with Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3110 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Knight Genetics and the general physician: insights, applications and future challenges QJM, November 1, 2009; 102(11): 757 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Cicek, S. L. Slager, S. J. Achenbach, A. J. French, H. E. Blair, S. R. Fink, N. R. Foster, B. F. Kabat, K. C. Halling, J. M. Cunningham, et al. Functional and Clinical Significance of Variants Localized to 8q24 in Colon Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2492 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kupfer, J. B. Torres, S. Hooker, J. R. Anderson, A. D. Skol, N. A. Ellis, and R. A. Kittles Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans Carcinogenesis, August 1, 2009; 30(8): 1353 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Song, S. J. Ramus, S. K. Kjaer, R. A. DiCioccio, G. Chenevix-Trench, C. L. Pearce, E. Hogdall, A. S. Whittemore, V. McGuire, C. Hogdall, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study Hum. Mol. Genet., June 15, 2009; 18(12): 2297 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gibson, N. Johnson, A. Fraser, I. dos Santos Silva, R. Houlston, J. Peto, and O. Fletcher No Breast Cancer Association for Transforming Growth Factor-{beta} Pathway Colorectal Cancer Single Nucleotide Polymorphisms Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1934 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Stanford, L. M. FitzGerald, S. K. McDonnell, E. E. Carlson, L. M. McIntosh, K. Deutsch, L. Hood, E. A. Ostrander, and D. J. Schaid Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage Hum. Mol. Genet., May 15, 2009; 18(10): 1839 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
Psychiatric GWAS Consortium Coordinating Committee Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders Am J Psychiatry, May 1, 2009; 166(5): 540 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. FitzGerald, E. M. Kwon, J. S. Koopmeiners, C. A. Salinas, J. L. Stanford, and E. A. Ostrander Analysis of Recently Identified Prostate Cancer Susceptibility Loci in a Population-based Study: Associations with Family History and Clinical Features Clin. Cancer Res., May 1, 2009; 15(9): 3231 - 3237. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Greenwald and B. K. Dunn Landmarks in the History of Cancer Epidemiology Cancer Res., March 15, 2009; 69(6): 2151 - 2162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wokolorczyk, J. Lubinski, S. A. Narod, and C. Cybulski Genetic Heterogeneity of 8q24 Region in Susceptibility to Cancer J Natl Cancer Inst, February 18, 2009; 101(4): 278 - 279. [Full Text] [PDF] |
||||
![]() |
Q. Zhao, O. L. Caballero, S. Levy, B. J. Stevenson, C. Iseli, S. J. de Souza, P. A. Galante, D. Busam, M. A. Leversha, K. Chadalavada, et al. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line PNAS, February 10, 2009; 106(6): 1886 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Curtin, W.-Y. Lin, R. George, M. Katory, J. Shorto, L. A. Cannon-Albright, D. T. Bishop, A. Cox, N. J. Camp, and Colorectal Cancer Study Group Meta Association of Colorectal Cancer Confirms Risk Alleles at 8q24 and 18q21 Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 616 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Closas and S. Chanock Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status Clin. Cancer Res., December 15, 2008; 14(24): 8000 - 8009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Park, S.-C. Chang, L. Cai, C. Cordon-Cardo, B.-G. Ding, S. Greenland, S. K. Hussain, Q. Jiang, S. Liu, M.-L. Lu, et al. Associations between Variants of the 8q24 Chromosome and Nine Smoking-Related Cancer Sites Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3193 - 3202. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Song, T. Koessler, S. Ahmed, S. J. Ramus, S. K. Kjaer, R. A. DiCioccio, E. Wozniak, E. Hogdall, A. S. Whittemore, V. McGuire, et al. Association Study of Prostate Cancer Susceptibility Variants with Risks of Invasive Ovarian, Breast, and Colorectal Cancer Cancer Res., November 1, 2008; 68(21): 8837 - 8842. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Easton and R. A. Eeles Genome-wide association studies in cancer Hum. Mol. Genet., October 15, 2008; 17(R2): R109 - R115. [Abstract] [Full Text] [PDF] |
||||









